Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Linoleamide)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST001680 AN002740 Metabolome of NAFLD in high fat diet mouse model Liver Mouse Fatty liver disease Weill Cornell Medicine Abundance
ST002758 AN004475 Metabolic responses of normal rat kidneys to a high salt intake (Plasma) Blood Rat Medical College of Wisconsin Area
ST002758 AN004477 Metabolic responses of normal rat kidneys to a high salt intake (Plasma) Blood Rat Medical College of Wisconsin Area
ST002760 AN004485 Metabolic responses of normal rat kidneys to a high salt intake (Kidney outer medulla) Kidney outer medulla Rat Medical College of Wisconsin Area
ST001143 AN001883 Microbial depletion and ozone exposure - Lung tissue (part I) Lung Mouse Asthma Harvard School of Public Health Area under curve
ST002051 AN003338 The apicomplexan parasite Toxoplasma gondii forms bradyzoite-containing tissue cysts that cause chronic and drug-tolerant infections. Cultured cells Toxoplasma gondii Parasitic infection Robert Koch-Institute counts
ST003362 AN005504 Metabolomics analysis of Glioblastoma (GBM) cell line U251 labeled by 13C-glutamine after treatment with pimozide Cultured cells Human Cancer The Ohio State University Counts
ST003362 AN005506 Metabolomics analysis of Glioblastoma (GBM) cell line U251 labeled by 13C-glutamine after treatment with pimozide Cultured cells Human Cancer The Ohio State University Counts
ST001403 AN002345 Ontogeny related changes in the pediatric liver metabolome (part-II) Liver Human Moffitt Cancer Center estimated abundances
ST001795 AN002915 Changes in mesenteric lymph lipid profile of mice upon high-fat diet with and without Celecoxib (part I) Mesenteric lymph Mouse Obesity Monash Institute of Pharmaceutical Sciences height
ST001796 AN002917 Changes in mesenteric lymph lipid profile of mice upon high-fat diet with and without Celecoxib Mesenteric lymph Mus musculus Diabetes Monash Institute of Pharmaceutical Sciences height
ST001788 AN002899 β-Adrenergic regulation of metabolism in macrophages (part-IV) Macrophages Human Monash University Intensity
ST003044 AN004994 A High-Fat Eucaloric Diet Induces Reprometabolic Syndrome of Obesity in Normal Weight Women - lipidomics Blood Human Obesity University of Colorado Denver peak area
ST000311 AN000495 TC and B6 untreated plasma in lupus-prone mice Blood Mouse Lupus University of Florida Peak area
ST002461 AN004015 Untargeted metabolomics of HUVECs subjected to hypoxia-reoxygenation Cultured cells Human Hypoxia Tulane University School of Medicine Peak area
ST003348 AN005483 An integrated LC-MS analysis of the biometric characteristics of different time cohorts of race walkers - untargeted Blood Human The First Affiliated Hospital of Dalian Medical University Peak area
ST003053 AN005006 Providing insight into the mechanism of action of Cationic Lipidated Oligomers (CLOs) using metabolomics Bacterial cells Staphylococcus aureus Bacterial infection Monash University peak height
ST000311 AN000497 TC and B6 untreated plasma in lupus-prone mice Blood Mouse Lupus University of Florida Peak height
ST000403 AN000642 Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes Cells Human Monash Institute of Pharmaceutical Sciences, Monash University Peak height
ST000539 AN000818 Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes (part II) Cells Human Monash Institute of Pharmaceutical Sciences, Monash University Peak height
ST001275 AN002116 Metabolomics-based profiling of the mode of action of Pathogen Box compounds in Trypanosoma brucei (part-II) Cultured cells Trypanosoma brucei Sleeping sickness Monash University Peak height
ST000421 AN000663 ms3076 T1D poor glycemic control and control samples Blood Human Diabetes Mayo Clinic Peak intensity
ST000421 AN000665 ms3076 T1D poor glycemic control and control samples Blood Human Diabetes Mayo Clinic Peak intensity
ST000422 AN000669 Type 1 Diabetes good glycemic control and controls samples Blood Human Diabetes Mayo Clinic Peak intensity
ST001205 AN002006 Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites Cultured cells Human Malaria Monash University Peak intensity
ST001205 AN002006 Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University Peak intensity
ST001547 AN002576 β-Adrenergic regulation of metabolism in macrophages Macrophages Human Monash University Peak intensity
ST001548 AN002578 β-Adrenergic regulation of metabolism in macrophages (part-II) Macrophages Human Monash University Peak intensity
ST001549 AN002580 β-Adrenergic regulation of metabolism in macrophages (part-III) Macrophages Human Monash University Peak intensity
ST000451 AN000707 The alpha-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid-Heart raw data Muscle Mouse University of North Carolina Peak values (scaled)
ST000452 AN000708 The alpha-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid-Serum raw data Blood Mouse University of North Carolina Peak values (scaled)
ST000899 AN001463 Alterations in Lipid, Amino Acid, and Energy Metabolism Distinguish Crohn Disease from Ulcerative Colitis and Control Subjects by Serum Metabolomic Profiling Blood Human Inflammatory bowel disease Vanderbilt University Medical Center raw area counts
ST002094 AN003420 Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) Feces Human Irritable bowel syndrome Mayo Clinic raw intensity
ST002094 AN003421 Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) Feces Human Irritable bowel syndrome Mayo Clinic raw intensity
ST000047 AN000081 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) Cerebrospinal fluid Human Alzheimers disease Mayo Clinic Raw MS Intensities
ST001404 AN002346 Ontogeny related changes in the pediatric liver metabolome (part-III) Liver Human Moffitt Cancer Center Relative Abundance
ST002017 AN003287 Multi-omic analysis of the microbiome and metabolome in healthy subjects (blood) Blood Human Vanderbilt University Medical Center scaled imputed
ST002018 AN003288 Multi-omic analysis of the microbiome and metabolome in healthy subjects (feces) Feces Human Vanderbilt University Medical Center scaled imputed
ST000974 AN001595 GC6-74 matabolomic of TB (Part 1: Plasma) Blood Human Tuberculosis Max Planck Institute for Infection Biology scaled units
ST001175 AN001950 Multi-omics analysis demonstrates unique mode of action of a potent new antimalarial compound, JPC-3210, against Plasmodium falciparum Plasmodium cells Plasmodium falciparum Malaria Monash University Signal Intensity
  logo